These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9513718)

  • 41. Production of proteins in the milk of transgenic livestock: problems, solutions, and successes.
    Colman A
    Am J Clin Nutr; 1996 Apr; 63(4):639S-45S. PubMed ID: 8599332
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Urine as a substitute for milk?
    Meade H; Ziomek C
    Nat Biotechnol; 1998 Jan; 16(1):21-2. PubMed ID: 9447585
    [No Abstract]   [Full Text] [Related]  

  • 43. Cloned transgenic cattle produce milk with higher levels of beta-casein and kappa-casein.
    Brophy B; Smolenski G; Wheeler T; Wells D; L'Huillier P; Laible G
    Nat Biotechnol; 2003 Feb; 21(2):157-62. PubMed ID: 12548290
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Large scale production of RH-albumin expressed in the milk of transgenic cattle--an economic and technical challenge.
    Eichner W; Sommermeyer K
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Dec; 34(12):777-8. PubMed ID: 10665316
    [No Abstract]   [Full Text] [Related]  

  • 45. Influence of lactation parameters on the N-glycosylation of recombinant human C1 inhibitor isolated from the milk of transgenic rabbits.
    Koles K; van Berkel PH; Mannesse ML; Zoetemelk R; Vliegenthart JF; Kamerling JP
    Glycobiology; 2004 Nov; 14(11):979-86. PubMed ID: 15253928
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pilot production of recombinant human clotting factor IX from transgenic sow milk.
    Sun YL; Chang YS; Lin YS; Yen CH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jun; 898():78-89. PubMed ID: 22578515
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human recombinant butyrylcholinesterase purified from the milk of transgenic goats interacts with beta-amyloid fibrils and suppresses their formation in vitro.
    Podoly E; Bruck T; Diamant S; Melamed-Book N; Weiss A; Huang Y; Livnah O; Langermann S; Wilgus H; Soreq H
    Neurodegener Dis; 2008; 5(3-4):232-6. PubMed ID: 18322399
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transgenic animal production and animal biotechnology.
    Robl JM; Wang Z; Kasinathan P; Kuroiwa Y
    Theriogenology; 2007 Jan; 67(1):127-33. PubMed ID: 17070901
    [TBL] [Abstract][Full Text] [Related]  

  • 49. On-line casein micelle disruption for downstream purification of recombinant human myelin basic protein produced in the milk of transgenic cows.
    Al-Ghobashy MA; Williams MA; Brophy B; Laible G; Harding DR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jun; 877(16-17):1667-77. PubMed ID: 19419911
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human and bovine lactoferrins in the milk of recombinant human lactoferrin-transgenic dairy cows during lactation.
    Hyvönen P; Suojala L; Haaranen J; von Wright A; Pyörälä S
    Biotechnol J; 2006 Apr; 1(4):410-2. PubMed ID: 16892268
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Milking the genome for profit.
    Dove A
    Nat Biotechnol; 2000 Oct; 18(10):1045-8. PubMed ID: 11017040
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protein profile and alpha-lactalbumin concentration in the milk of standard and transgenic goats expressing recombinant human butyrylcholinesterase.
    Baldassarre H; Schirm M; Deslauriers J; Turcotte C; Bordignon V
    Transgenic Res; 2009 Aug; 18(4):621-32. PubMed ID: 19296233
    [TBL] [Abstract][Full Text] [Related]  

  • 53. State of the art in the production of transgenic goats.
    Baldassarre H; Wang B; Keefer CL; Lazaris A; Karatzas CN
    Reprod Fertil Dev; 2004; 16(4):465-70. PubMed ID: 15315745
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of human alpha 1 antitrypsin in transgenic sheep.
    Carver A; Wright G; Cottom D; Cooper J; Dalrymple M; Temperley S; Udell M; Reeves D; Percy J; Scott A
    Cytotechnology; 1992; 9(1-3):77-84. PubMed ID: 1369184
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The past, present and future of transgenic bioreactors.
    Drohan WN
    Thromb Haemost; 1997 Jul; 78(1):543-7. PubMed ID: 9198212
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Livestock production and animal health in Sicily, Italy.
    Caracappa S
    Parassitologia; 1999 Sep; 41 Suppl 1():17-23. PubMed ID: 11071536
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetically engineered livestock: closer than we think?
    Maga EA
    Trends Biotechnol; 2005 Nov; 23(11):533-5. PubMed ID: 16150502
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Advancing mammalian cell culture engineering using genome-scale technologies.
    Griffin TJ; Seth G; Xie H; Bandhakavi S; Hu WS
    Trends Biotechnol; 2007 Sep; 25(9):401-8. PubMed ID: 17681628
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Developing efficient strategies for the generation of transgenic cattle which produce biopharmaceuticals in milk.
    Brink MF; Bishop MD; Pieper FR
    Theriogenology; 2000 Jan; 53(1):139-48. PubMed ID: 10735069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.